---
figid: PMC7037748__ijms-21-01098-g002
figtitle: Regulation of the Wnt/Beta-catenin signaling pathway when it is inactive
  (OFF) and when it is active (ON)
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7037748
filename: ijms-21-01098-g002.jpg
figlink: pmc/articles/PMC7037748/figure/ijms-21-01098-f002/
number: F2
caption: 'Schematic representation of the regulation of the Wnt/β-catenin signaling
  pathway when it is inactive (OFF) and when it is active (ON). OFF: ZNRF3 and RNF43
  are transmembrane molecules that downregulate Wnt/β-catenin signaling. They promote
  the ubiquitination (UB) and lysosomal degradation of Fzd and LRP5/6. Secreted SFRP,
  APCDD1, and WIF can directly bind Fzd to prevent activation of receptors. Other
  Wnt antagonists, Dkk1 and Wise, inhibit by binding to the co-receptors LRP5/6. GRG/TLE,
  CtBP1, and HDAC negatively control Wnt/β-catenin pathway binding to TCF. ON: The
  Wnt agonists R-spondins interact on the cell surface with members of the LGR4/5
  family to enhance Wnt signaling. Binding of R-spondin to ZNRF3/RNF43 inhibits ZNRF3,
  which enhances the Wnt/β-catenin pathway activity. Norrin acts by interacting with
  Fzd4 and requiring LRP5/6 for its activation. Arrows show activation while T-bars
  show inhibition.'
papertitle: The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic
  Leukemia.
reftext: Francesca Chiarini, et al. Int J Mol Sci. 2020 Feb;21(3):1098.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9497818
figid_alias: PMC7037748__F2
figtype: Figure
redirect_from: /figures/PMC7037748__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7037748__ijms-21-01098-g002.html
  '@type': Dataset
  description: 'Schematic representation of the regulation of the Wnt/β-catenin signaling
    pathway when it is inactive (OFF) and when it is active (ON). OFF: ZNRF3 and RNF43
    are transmembrane molecules that downregulate Wnt/β-catenin signaling. They promote
    the ubiquitination (UB) and lysosomal degradation of Fzd and LRP5/6. Secreted
    SFRP, APCDD1, and WIF can directly bind Fzd to prevent activation of receptors.
    Other Wnt antagonists, Dkk1 and Wise, inhibit by binding to the co-receptors LRP5/6.
    GRG/TLE, CtBP1, and HDAC negatively control Wnt/β-catenin pathway binding to TCF.
    ON: The Wnt agonists R-spondins interact on the cell surface with members of the
    LGR4/5 family to enhance Wnt signaling. Binding of R-spondin to ZNRF3/RNF43 inhibits
    ZNRF3, which enhances the Wnt/β-catenin pathway activity. Norrin acts by interacting
    with Fzd4 and requiring LRP5/6 for its activation. Arrows show activation while
    T-bars show inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - RNF43
  - ZNRF3
  - RSPO1
  - DKK1
  - APCDD1
  - SOST
  - LRP6
  - LRP5
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LGR4
  - LGR5
  - CTNNB1
  - TLE5
  - TLE1
  - TLE2
  - TLE3
  - TLE4
  - TLE6
  - TLE7
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - TLE
---
